BioNxt Solutions (TSE:BNXT) has released an update.
BioNxt Solutions Inc., a bioscience accelerator, has announced the extension of the expiry dates for nearly 1.9 million Warrants, allowing holders to purchase company shares at a set price until 2025. The move reflects the company’s growth strategy and commitment to investors, as it continues to focus on the development of drug formulations, diagnostic tests, and active pharmaceutical ingredients, primarily targeting the European market.
For further insights into TSE:BNXT stock, check out TipRanks’ Stock Analysis page.
